Amiloidózis: vizsgálatok itt: Svájc
5 of 8 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleTRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Where
- Basel, Bern, Geneva, Lucerne, Sankt Gallen
- Életkor
- 18 év to 85 év
- People
- 2250 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07052903 · EU 2024-519917-72-00 - 3. fázisTaking peopleTRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Where
- Bern
- Életkor
- 18 év to 85 év
- People
- 125 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07223203 · EU 2025-522544-40-00 - 3. fázisNot yet taking people in SvájcAn Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
- Where
- Basel, Bern, Lucerne, Sankt Gallen, Zurich
- People
- 1180 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483 · EU 2026-526755-57-00 - No phaseNot yet taking people in SvájcEarly Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging
- Where
- Zurich
- Életkor
- 18 év and over
- People
- 50
- Run by
- University of Zurich
See details and how to joinNCT07624760 - No phaseTaking peopleMultimodality Cardiac Imaging for Disease Progression in ATTR-CM
- Where
- Zurich
- People
- 50
- Run by
- Dominik Benz
See details and how to joinNCT07112066